P1013: CBL MUTATION MAY BE ASSOCIATED WITH THE ONSET OF MYELOPROLIFERATIVE NEOPLASMS WITH MICROVASCULAR DISORDERS: A SINGLE-CENTRE EXPERIENCE

P1013: CBL MUTATION MAY BE ASSOCIATED WITH THE ONSET OF MYELOPROLIFERATIVE NEOPLASMS WITH MICROVASCULAR DISORDERS: A SINGLE-CENTRE EXPERIENCE

Bibliographic Details
Main Authors:	Giorgia Micucci, Agnese Mattei, Monica Poggiaspalla, Gerardo Musuraca, Federica Frabetti, Flavia Foca, Giulio Giordano, Mariasanta Napolitano, Alessandro Lucchesi
Format:	Article
Language:	English
Published:	Wiley 2023-08-01
Series:	HemaSphere
Online Access:	http://journals.lww.com/10.1097/01.HS9.0000970956.43764.3d

Similar Items

Circulating Endothelial Cell Levels Correlate with Treatment Outcomes of Splanchnic Vein Thrombosis in Patients with Chronic Myeloproliferative Neoplasms
by: Giulio Giordano, et al.
Published: (2022-02-01)

P992: OUTCOMES OF GLOBAL COAGULATION ASSAYS IN PATIENTS WITH PHILADELPHIA-NEGATIVE MYELOPROLIFERATIVE NEOPLASMS WITH RESPECT TO THEIR CLINICAL AND GENETIC DETERMINANTS OF CLONAL EVOLUTION
by: A. Lucchesi, et al.
Published: (2022-06-01)

Platelets Contribution to Thrombin Generation in Philadelphia-Negative Myeloproliferative Neoplasms: The “Circulating Wound” Model
by: Alessandro Lucchesi, et al.
Published: (2021-10-01)

Genetics and Pathogenetic Role of Inflammasomes in Philadelphia Negative Chronic Myeloproliferative Neoplasms: A Narrative Review
by: Valeria Di Battista, et al.
Published: (2021-01-01)

Chronic myeloproliferative neoplasm in adulthood in CBL syndrome harboring a splice‐site CBL variant alongside a novel constitutional CSF3R variant
by: George Mason, et al.
Published: (2024-04-01)

Myeloproliferative neoplasms
by: Jean-Jacques Kiladjian
Published: (2018-06-01)

Myeloproliferative neoplasms
by: Nick Cross, (Coordinating Author)
Published: (2019-06-01)

The microenvironment in myeloproliferative neoplasm
by: Simón Méndez-Ferrer, et al.
Published: (2018-06-01)

Spleen in myeloproliferative neoplasms
by: Giovanni Barosi
Published: (2018-06-01)

Aetiology of Myeloproliferative Neoplasms
by: Mary Frances McMullin, et al.
Published: (2020-07-01)

Epigenetics in myeloproliferative neoplasms
by: Graeme Greenfield, et al.
Published: (2023-07-01)

Myeloproliferative neoplasm stem cells
by: Mead, A, et al.
Published: (2017)

Mutant Calreticulin in the Myeloproliferative Neoplasms
by: Daniel Prins, et al.
Published: (2020-02-01)

Interferons in the treatment of myeloproliferative neoplasms
by: Pankit Vachhani, et al.
Published: (2024-02-01)

Neurological Findings in Myeloproliferative Neoplasms
by: Semra Paydas
Published: (2013-04-01)

Novel therapeutics in myeloproliferative neoplasms
by: Sangeetha Venugopal, et al.
Published: (2020-12-01)

Targeted therapies for myeloproliferative neoplasms
by: Bing Li, et al.
Published: (2019-07-01)

CALR Mutations in Myeloproliferative Neoplasms
by: Ken-Hong Lim
Published: (2014-06-01)

Understanding Aberrant Signaling to Elude Therapy Escape Mechanisms in Myeloproliferative Neoplasms
by: Maria Teresa Bochicchio, et al.
Published: (2022-02-01)

Classification and personalized prognosis in myeloproliferative neoplasms
by: Grinfeld, J, et al.
Published: (2018)

Heterogeneity in myeloproliferative neoplasms: causes and consequences
by: O'Sullivan, J, et al.
Published: (2018)

Mechanisms of disease transformation in myeloproliferative neoplasms
by: O'Sullivan, J
Published: (2022)

Functional Consequences of Mutations in Myeloproliferative Neoplasms
by: Stefan N. Constantinescu, et al.
Published: (2021-06-01)

Genetic Aspects of Myelodysplastic/Myeloproliferative Neoplasms
by: Laura Palomo, et al.
Published: (2021-04-01)

Clonal Hematopoiesis and Mutations of Myeloproliferative Neoplasms
by: Lasse Kjær
Published: (2020-07-01)

NK Cells in Myeloproliferative Neoplasms (MPN)
by: Erin Naismith, et al.
Published: (2021-08-01)

Dual Drivers in the Myeloproliferative Neoplasms: An Underestimation?
by: Stephen E. Langabeer PhD, FRCPath
Published: (2023-06-01)

Mutations, inflammation and phenotype of myeloproliferative neoplasms
by: Sylvie Hermouet, et al.
Published: (2023-05-01)

The Role of New Technologies in Myeloproliferative Neoplasms
by: Giuseppe A. Palumbo, et al.
Published: (2019-04-01)

Philadelphia-negative chronic myeloproliferative neoplasms
by: Rosane Isabel Bittencourt, et al.
Published: (2012-01-01)

Comparison and Implications of Mutational Profiles of Myelodysplastic Syndromes, Myeloproliferative Neoplasms, and Myelodysplastic/Myeloproliferative Neoplasms: A Meta-Analysis
by: Ziqi Wan, et al.
Published: (2020-10-01)

P754: INITIAL RESULTS OF PHASE I/II STUDY OF AZACITIDINE IN COMBINATION WITH QUIZARTINIB FOR PATIENTS WITH MYELODYSPLASTIC SYNDROME AND MYELODYSPLASTIC/MYELOPROLIFERATIVE NEOPLASM WITH FLT3 OR CBL MUTATION
by: T. Abuasab, et al.
Published: (2022-06-01)

Immune Thrombocytopenia in Antiphospholipid Syndrome: Is It Primary or Secondary?
by: Riccardo Tomasello, et al.
Published: (2021-09-01)

The aetiology and burden of myeloproliferative neoplasms in the United Kingdom: the MyelOproliferative neoplasmS: an In-depth case-control (MOSAICC) study protocol
by: Nouf Abutheraa, et al.
Published: (2023-12-01)

P10.13 WITHDRAWN
Published: (2014-11-01)

Challenges and Perspectives for Therapeutic Targeting of Myeloproliferative Neoplasms
by: Sime Brkic, et al.
Published: (2021-01-01)

Myeloproliferative Neoplasms: Contemporary Review and Molecular Landscape
by: Muftah Mahmud, et al.
Published: (2023-12-01)

QUALITY OF LIFE IN PATIENTS WITH MYELOPROLIFERATIVE NEOPLASMS (REVIEW)
by: I. L. Davydkin, et al.
Published: (2019-03-01)

Endothelium state in Ph-negative myeloproliferative neoplasms
by: N. E. Korsakova
Published: (2021-12-01)

Inflammation and anti-inflammatory approaches in myeloproliferative neoplasm
by: Steffen Koschmieder, et al.
Published: (2018-06-01)